Announce Date | 05/13/2024 |
EPS Normalized Actual | $-0.1 (Beat by $0.01) |
EPS GAAP Actual | $-0.1 (Beat by $0.01) |
Revenue Actual | $0.000114211B |
Revenue Surprise | Beat by $0.114211M |
Announce Date | 07/01/2024 (Pre-Market) |
EPS Normalized Estimate | $-0.092 |
EPS GAAP Estimate | $-0.092 |
Revenue Estimate | $0.000734B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 0.73 | 1.04 | 0.27889 | 1.30483 | 1 |
Dec 2026 | -0.01333 | -56.94 | -0.15 | 0.11 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.14 | -0.14 | 0.000114211B | 77.65% | 0.11M |
FQ4 2021 (Dec 2021) | 0.35 | 0.35 | 0B | NAN% | 0M |
FQ3 2021 (Sep 2021) | -0.13 | -0.13 | 2.5483E-5B | 97.74% | 0.03M |
FQ2 2021 (Jun 2021) | -0.1 | -0.1 | 2.4782E-5B | 79.06% | 0.02M |
FQ1 2021 (Mar 2021) | -0.12 | -0.12 | 2.553E-5B | 97.88% | 0.03M |
FQ4 2020 (Dec 2020) | 0 | 0 | 0B | NAN% | 0M |
FQ3 2020 (Sep 2020) | -0.09 | -0.09 | 5.75E-7B | -2873.91% | 0M |
FQ2 2020 (Jun 2020) | -0.12 | -0.12 | 5.19E-6B | 100% | 0.01M |
FQ4 Announce Date
07/01/2024 (Pre-Market)
Consensus EPS Estimates
-0.092
Consensus Revenue Estimates
0.000734B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | -0.06 | -- | -0.06709091 | -0.05404364 | 1 |
FQ3 2025 (Jul 2025) | -0.07 | -- | -0.07827273 | -0.06305091 | 1 |
FQ2 2025 (Jun 2025) | 0 | -- | 0 | 0 | 1 |
FQ1 2025 (Mar 2025) | 0 | -- | 0 | 0 | 1 |
FQ4 2024 (Oct 2024) | -0.082 | -- | -0.09169091 | -0.07385964 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0B | -- | 0B | 0B | 0 |
FQ3 2025 (Jul 2025) | 0B | -- | 0B | 0B | 0 |
FQ2 2025 (Jun 2025) | 0B | -- | 0B | 0.01B | 0 |
FQ1 2025 (Mar 2025) | 0B | -- | 0B | 0.01B | 0 |
FQ4 2024 (Oct 2024) | 0B | -- | 0B | 0B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
6
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
0
Revenue # of in-lines
2
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.14 | -0.14 | 100% | |
FQ4 2021 (Dec 2021) | 0.35 | 0.35 | 100% | |
FQ3 2021 (Sep 2021) | -0.13 | -0.13 | 100% | |
FQ2 2021 (Jun 2021) | -0.1 | -0.1 | 100% | |
FQ1 2021 (Mar 2021) | -0.12 | -0.12 | 100% | |
FQ4 2020 (Dec 2020) | 0 | 0 | NAN% | |
FQ3 2020 (Sep 2020) | -0.09 | -0.09 | 100% | |
FQ2 2020 (Jun 2020) | -0.12 | -0.12 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0B | $0.11M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0B | $0M | NAN% |
FQ3 2021 (Sep 2021) | $0B | $0B | $0.03M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0B | $0.02M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0B | $0.03M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0B | $0M | NAN% |
FQ3 2020 (Sep 2020) | $0B | $0B | $0M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0B | $0.01M | 100% |